Loading...

Kiniksa Pharmaceuticals, Ltd.

KNSANASDAQ
Healthcare
Biotechnology
$31.98
$1.72(5.68%)

Kiniksa Pharmaceuticals, Ltd. (KNSA) Stock Overview

Explore Kiniksa Pharmaceuticals, Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 72.9/100

Key Financials

Market Cap2.4B
P/E Ratio488.32
EPS (TTM)$0.05
ROE0.01%
Fundamental Analysis

AI Price Forecasts

1 Week$30.95
1 Month$30.27
3 Months$26.08
1 Year Target$28.01

KNSA Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Kiniksa Pharmaceuticals, Ltd. (KNSA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 67.56, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.01.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 488.32 and a market capitalization of 2.4B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Frequently Asked Questions

;